Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.

Gao JM, Cai F, Peng M, Ma Y, Wang B.

Chin Med J (Engl). 2013 Jun;126(12):2229-34.

PMID:
23786930
2.

Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.

Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S.

Chest. 2006 Dec;130(6):1726-32.

PMID:
17166989
4.

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.

Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A.

Am J Respir Crit Care Med. 2002 Jan 1;165(1):9-14.

PMID:
11779723
5.

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.

N Engl J Med. 1998 Jul 16;339(3):147-52.

6.

Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.

Zhang J, Yu C, Noonan G, Reiss TF.

Clin Ther. 2002 Apr;24(4):574-82.

PMID:
12017402
7.

A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics.

Currie GP, Lee DK, Dempsey OJ, Fowler SJ, Cowan LM, Lipworth BJ.

Br J Clin Pharmacol. 2003 Jun;55(6):609-15.

8.
10.

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J.

Clin Exp Allergy. 2001 Jun;31(6):845-54.

PMID:
11422148
11.

Effect of montelukast on peripheral airflow obstruction in children with asthma.

Spahn JD, Covar RA, Jain N, Gleason M, Shimamoto R, Szefler SJ, Gelfand EW.

Ann Allergy Asthma Immunol. 2006 Apr;96(4):541-9.

PMID:
16680924
12.

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.

Tohda Y, Fujimura M, Taniguchi H, Takagi K, Igarashi T, Yasuhara H, Takahashi K, Nakajima S.

Clin Exp Allergy. 2002 Aug;32(8):1180-6.

PMID:
12190656
13.

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.

Altman LC, Munk Z, Seltzer J, Noonan N, Shingo S, Zhang J, Reiss TF.

J Allergy Clin Immunol. 1998 Jul;102(1):50-6.

PMID:
9679847
14.

Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.

Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST.

Thorax. 2002 Apr;57(4):323-7.

15.

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.

Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.

Ann Allergy Asthma Immunol. 2004 Jun;92(6):641-8.

PMID:
15237766
16.

Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.

Phipatanakul W, Greene C, Downes SJ, Cronin B, Eller TJ, Schneider LC, Irani AM.

Ann Allergy Asthma Immunol. 2003 Jul;91(1):49-54.

PMID:
12877449
17.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
18.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
19.

Montelukast improves regional air-trapping due to small airways obstruction in asthma.

Zeidler MR, Kleerup EC, Goldin JG, Kim HJ, Truong DA, Simmons MD, Sayre JW, Liu W, Elashoff R, Tashkin DP.

Eur Respir J. 2006 Feb;27(2):307-15.

20.

Effectiveness of montelukast in the treatment of cough variant asthma.

Spector SL, Tan RA.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):232-6.

PMID:
15478381

Supplemental Content

Support Center